Acylated heptapeptide binds albumin with high affinity and application as tag furnishes long-acting peptides
A major challenge for the application of peptide therapeutics is their short half-lifein vivo. Here, the authors design peptide-fatty acid chimeras bearing an engineered linker that promotes albumin binding and allows longer circulation times of therapeutic peptides in animal models.
Guardado en:
Autores principales: | Alessandro Zorzi, Simon J. Middendorp, Jonas Wilbs, Kaycie Deyle, Christian Heinis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cb4c3effd8b24083a11b07d420333e2b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs
por: Jonas Wilbs, et al.
Publicado: (2020) -
Selective N-terminal acylation of peptides and proteins with a Gly-His tag sequence
por: Manuel C. Martos-Maldonado, et al.
Publicado: (2018) -
Development of Series of Affinity Tags in Streptomyces
por: Xu-Ming Mao, et al.
Publicado: (2017) -
Multicomponent mapping of boron chemotypes furnishes selective enzyme inhibitors
por: Joanne Tan, et al.
Publicado: (2017) -
Carbon stored by furnishing wood-based products: An Italian case study
por: Negro,Francesco, et al.
Publicado: (2019)